Composition and methods for determining the activity of DNA-binding proteins and of initiation of trascription

• US 6,284,468 B1
• Filed: 06/13/2000
• Issued: 09/04/2001
• Est. Priority Date: 06/24/1999
• Status: Expired due to Fees

• Current Assignee: DNA Diagnostics Incorporated
• Original Assignee: DNA Diagnostics Incorporated
• Inventors: Morgan, Robert Charles, Severini, Alberto
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): WILDER, CYNTHIA B
• Application Number:
  US09/594,108
• Time in Patent Office: 448 Days
• Field of Search: 435/6, 435/7.1, 435/199, 435/196, 435/320.1, 435/91.2, 536/23.1, 536/24.1
• US Class Current: 435/6.12
• CPC Class Codes: C12N 15/1034 Isolating an individual clone by screening libraries

Abstract

This invention provides plasmids that are useful in detecting and determining the DNA-binding activity of sequence-specific DNA-binding molecules. The invention further provides plasmids that are useful in detecting and determining the activity of RNA polymerases in initiating transcription. In particular, the invention relates to plasmids that contain unique restriction sites and cognate nucleotide recognition sequences for sequence-specific DNA-binding molecules. Also provided are methods for using the plasmids disclosed herein.

Claims

1. A method for detecting the presence of initiation of transcription activity by RNA polymerase, comprising:

(a) providing;

(i) a test sample suspected of comprising RNA polymerase which specifically binds to a first nucleotide sequence;

(ii) a restriction enzyme which binds to a second nucleotide sequence and which cleaves a DNA sequence at a restriction site;

(iii) a recombinant plasmid comprising said first and second nucleotide sequences and said restriction site, wherein said restriction site is located at a position selected from being comprised within said first nucleotide sequence, being comprised within said second nucleotide sequence, being substantially adjacent to said first nucleotide sequence, and being substantially adjacent to said second nucleotide sequence; and

(iv) a mixture of ribonucleotide triphosphates;

(b) contacting said test sample with said recombinant plasmid to generate a contacted test sample, wherein said contacting is under conditions such that said RNA polymerase specifically binds to said first nucleotide sequence in said recombinant plasmid to form a bound plasmid;

(c) treating said contacted test sample with said restriction enzyme to generate a treated test sample, wherein the treatment is under conditions such that said bound plasmid is not substantially cleaved by said restriction enzyme;

(d) mixing said treated test sample with said mixture of ribonucleotide triphosphates to generate a mixed test sample; and

(e) detecting the presence of uncleaved plasmid in said mixed test sample thereby detecting the presence of said initiation of transcription activity by said RNA polymerase in said test sample.

2. The method of claim 1, wherein instead of steps e) said method comprises e) detecting the presence of cleaved plasmid in said mixed test sample thereby detecting the presence of said initiation of transcription activity by said RNA polymerase in said test sample.

8. The method of claim 1, wherein said test sample further comprises an inhibitor of initiation of transcription activity.

9. The method of claim 1, wherein said restriction site is comprised within the first nucleotide sequence, and the plasmid is pDNABtac.

10. The method of claim 1, wherein said restriction site is substantially adjacent to the second nucleotide sequence, and said plasmid is pDNABtac.

11. The method of claim 1, wherein said restriction enzyme is selected from AatII, AccI, AflII, AflIII, AhaII, AluI, AlwI, AlwNI, ApaI, ApaLI, AseI, Asp718, AvaI, AvaII, AvrII, BalI, BamHI, BanI, BanII, BbeI, BbvI, BbvII, BcII, BcnI, BglI, BglII, BseRI, BsmI, BsmAI, Bsp1286I, BspHI, BspMI, BspMII, BsrI, BssHII, BstBI, BstEII, BstNI, BstUI, BstXI, BstYI, Bsu36I, CfrlOI, ClaI, DdeI, DpnI, DraI, DraIII, EaeI, EagI, EarI, Eco47III, EcoNI, Eco0109I, EcoRI, EcoRII, EcoRV, EspI, Fnu4HI, FokI, FspI, GdiII, HaeI, HaeII, HaeIII, HgaI, HgiAI, HhaI, HinCII, HinDIII, HinfI, HinPI, HpaI, HpaII, HphI, KpnI, MaeI, MaeII, MaeIII, MboI, MboII, MluI, MnlI, MseI, MspI, NaeI, NarI, NciI, NcoI, NdeI, NheI, NlaIII, NlaIV, NotI, NruI, NsiI, Nsp7524I, NspBII, NspHI, PaeR7I, PflMI, PleI, PpuMI, PstI, PvuI, PvuII, RsaI, RsrII, SacI, SacII, SalI, Sau3AI, Sau96I, ScaI, ScrFI, SecI, SfaNI, SfiI, SmaI, SnaBI, SpeI, SphI, SplI, SspI, StuI, StyI, TaqI, TthlllI, TthlllII, XbaI, XcaI, XhoI, XmaI, XmnI.

12. The method of claim 1, wherein said RNA polymerase is selected from T7 bacteriophage RNA polymerase, T3 bacteriophage RNA polymerase, SP6 bacteriophage RNA polymerase, eukaryotic RNA polymerase I, eukaryotic RNA polymerase II, eukaryotic RNA polymerase III, PBS1 phage RNA polymerase, PBS2 phage RNA polymerase, vaccinia virus RNA polymerase, Escherichia coli RNA polymerase, and mitochondrion RNA polymerase.

3. A method for determining initiation of transcription activity by RNA polymerase, comprising:

(a) providing;

(i) a test sample suspected of comprising RNA polymerase which specifically binds to a first nucleotide sequence;

(ii) a plurality of samples comprising known amounts of said RNA polymerase;

(iii) a restriction enzyme which binds to a second nucleotide sequence and which cleaves a DNA sequence at a restriction site;

(iv) a recombinant plasmid comprising said first and second nucleotide sequences and said restriction site, wherein said restriction site is located at a position selected from being comprised within said first nucleotide sequence, being comprised within said second nucleotide sequence, being substantially adjacent to said first nucleotide sequence, and being substantially adjacent to said second nucleotide sequence; and

(v) a mixture of ribonucleotide triphosphates;

(b) contacting said test sample with said recombinant plasmid to generate a contacted test sample and contacting said plurality of samples with said recombinant plasmid to generate a contacted plurality of samples, wherein said contacting is under conditions such that said RNA polymerase specifically binds to said first nucleotide sequence in said recombinant plasmid to form a bound plasmid;

(c) treating said contacted test sample with said restriction enzyme to generate a treated test sample and treating said contacted plurality of samples with said restriction enzyme to generate a treated plurality of samples, wherein the treatment is under conditions such that said bound plasmid is not substantially cleaved by said restriction enzyme;

(d) mixing said treated test sample with said mixture of ribonucleotide triphosphates to generate a mixed test sample and mixing said treated plurality of samples with said mixture of ribonucleotide triphosphates to generate a mixed plurality of samples; and

(e) comparing the amount of uncleaved plasmid in said mixed test sample with the amount of uncleaved plasmid in said mixed plurality of samples, thereby determining initiation of transcription activity of said RNA polymerase in said test sample.

4. The method of claim 3, wherein instead of steps e) said method comprises e) comparing the amount of cleaved plasmid in said treated test sample with the amount of cleaved plasmid in said treated plurality of samples, thereby determining transcription activity of said RNA polymerase in said test sample.

5. The method of claim 3, wherein said test sample further comprises an inhibitor of initiation of transcription activity.

6. The method of claim 3, wherein said restriction site is comprised within said first nucleotide sequence, and said plasmid is pDNABtac.

7. The method of claim 3, wherein said restriction site is substantially adjacent to said second nucleotide sequence, and said plasmid is pDNABtac.

13. The method of claim 3, wherein said restriction enzyme is selected from AatII, AccI, AflII, AflIII, AhaII, AluI, AlwI, AlwNI, ApaI, ApaLI, AseI, Asp718, AvaI, AvaII, AvrII, BalI, BamHI, BanI, BanII, BbeI, BbvI, BbvII, BclI, BcnI, BglI, BglII, BseRI, BsmI, BsmAI, Bsp1286I, BspHI, BspMI, BspMII, BsrI, BssHII, BstBI, BstEII, BstNI, BstUI, BstXI, BstYI, Bsu36I, CfrlOI, ClaI, DdeI, DpnI, DraI, DraIII, EaeI, EagI, EarI, Eco47III, EcoNI, Eco0109I, EcoRI, EcoRII, EcoRV, EspI, Fnu4HI, FokI, FspI, GdiII, HaeI, HaeII, HaeIII, HgaI, HgiAI, HhaI, HinCII, HinDIII, HinfI, HinPI, HpaI, HpalI, HphI, KpnI, MaeI, MaeII, MaeIII, MboI, MboII, MluI, MnlI, MseI, MspI, NaeI, NarI, NciI, NcoI, NdeI, NheI, NlaIII, NlaIV, NotI, NruI, NsiI, Nsp7524I, NspBII, NspHI, PaeR7I, PflMI, PleI, PpuMI, PstI, PvuI, PvuII, RsaI, RsrII, SacI, SacII, SalI, Sau3AI, Sau96I, ScaI, ScrFI, SecI, SfaNI, SfiI, SmaI, SnaBI, SpeI, SphI, SplI, SspI, StuI, StyI, TaqI, TthlllI, TthlllII, XbaI, XcaI, XhoI, XmaI, XmnI.

14. The method of claim 3, wherein said RNA polymerase is selected from T7 bacteriophage RNA polymerase, T3 bacteriophage RNA polymerase, SP6 bacteriophage RNA polymerase, eukaryotic RNA polymerase I, eukaryotic RNA polymerase II, eukaryotic RNA polymerase III, PBS1 phage RNA polymerase, PBS2 phage RNA polymerase, vaccinia virus RNA polymerase, Escherichia coli RNA polymerase, and mitochondrion RNA polymerase.